These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6784922)

  • 21. Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.
    Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM
    Cancer Treat Rep; 1980; 64(2-3):323-6. PubMed ID: 6773656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.
    Hartenbach EM; Harris LS; Bailey HH; Grosen EA; Larrison E; Chen D; Twiggs LB; Schink JC
    Cancer J Sci Am; 1999; 5(6):348-55. PubMed ID: 10606476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-dose chemotherapy in ovarian adenocarcinoma].
    Lotz JP; Lhommé C; Pautier P; Couteau C; Gligorov J; Alexandre J; Selle F; Izrael V; Maraninchi D; Viens P
    Bull Cancer; 2000 Jan; 87(1):63-9. PubMed ID: 10673633
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.
    Sessa C; Colombo N; Bolis G; Marsoni S; Mangioni C
    Cancer Treat Rev; 1991 Mar; 18 Suppl A():37-46. PubMed ID: 1904308
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy of epithelial ovarian carcinoma].
    Bruntsch U; Gallmeier WM
    MMW Munch Med Wochenschr; 1983 Nov; 125(44):993-5. PubMed ID: 6417517
    [No Abstract]   [Full Text] [Related]  

  • 26. Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma.
    Tempero MA; Kessinger A
    J Surg Oncol; 1982 Nov; 21(3):159-61. PubMed ID: 6813600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polymer-drug complexes in the treatment of extensive ovarian cancer].
    Novikova EG; Borisov VI; Dmitriev DG; Zel'vin BM; Karseladze AI; Shchitkov KG; Li AD
    Sov Med; 1991; (11):27-9. PubMed ID: 1767307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE; Einhorn L; Stehman FB; Blessing J
    Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma].
    Gershanovich ML; Livshits ME; Antipenkova VI
    Vopr Onkol; 2000; 46(5):604-7. PubMed ID: 11202196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinoma.
    Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Kooyman CD; van Houwelingen JC; Pinedo HM
    Cancer; 1984 Apr; 53(7):1467-72. PubMed ID: 6421472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of ovarian cancer with a combination of cis-platinum, adriamycin, cyclophosphamide and hexamethylmelamine.
    Razis DV; Poulakou E; Petounis A; Papadimitriou G; Kosmides P; Delides G
    Oncology; 1982; 39(4):205-8. PubMed ID: 6806735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule and dosage modification of a cyclophosphamide, hexamethylmelamine, doxorubicin, cisplatin combination chemotherapy regimen for refractory ovarian cancer.
    Bruckner HW; Cohen CJ; Bhardwaj S; Feuer E; Chesser MR; Holland JF
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1273-9. PubMed ID: 2509207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 34. cis-Dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: a phase II study.
    Lund B; Aabo K; Rørth M; Hansen HH
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1089-92. PubMed ID: 6819145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The case for combination chemotherapy in the treatment of advanced ovarian cancer.
    Ozols RF
    J Clin Oncol; 1985 Nov; 3(11):1445-7. PubMed ID: 3932603
    [No Abstract]   [Full Text] [Related]  

  • 36. Altretamine (hexamethylmelamine) in platinum-resistant and platinum-refractory ovarian cancer: a Gynecologic Oncology Group phase II trial.
    Markman M; Blessing JA; Moore D; Ball H; Lentz SS
    Gynecol Oncol; 1998 Jun; 69(3):226-9. PubMed ID: 9648592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hexamethylmelamine, vincristine, and methotrexate chemotherapy in advanced neoplasms.
    Longacre D; Donavan M; Paladine W; Cunningham T; Sponzo R
    Cancer Treat Rep; 1977 Aug; 61(5):919-22. PubMed ID: 408004
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?
    Foster BJ; Clagett-Carr K; Marsoni S; Simon R; Leyland-Jones B
    Cancer Treat Rep; 1986 Aug; 70(8):1003-14. PubMed ID: 3089597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternating multiagent chemotherapy for advanced ovarian cancer.
    Hernandez E; Rosenshein NB; Villar J; Dillon MB; Ettinger DS; Order SE
    J Surg Oncol; 1983 Feb; 22(2):87-91. PubMed ID: 6296547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.